Visit our Covid-19 microsite for the latest coronavirus news, analysis and updates


Follow the latest updates of the outbreak on our timeline.

Discover B2B Marketing That Performs

Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.

Find out more

US-based Co-Diagnostics has launched a research use only (RUO) CoPrimer test for new coronavirus (2019-nCoV).

The company launched the product just weeks after it completed principle design work for the test to address the growing need for testing designs to detect the presence of coronavirus.

To date, the coronavirus outbreak killed 638 people, with a total of 31,428 infection cases now confirmed.

The Logix Smart 2019-nCoV coronavirus test is now available for sale to laboratories, hospitals and institutions.

GlobalData Strategic Intelligence

US Tariffs are shifting - will you react or anticipate?

Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.

By GlobalData

Designed leveraging the company’s CoDx Design software system, the test helps in identifying the most optimal target on the 2019-nCoV genome for a PCR assay.

Co-Diagnostics expects that the test will ensure greater accuracy in detecting the presence of the coronavirus.

Co-Diagnostics CEO Dwight Egan said: “Leveraging our proprietary design process and software has allowed us to quickly move this product from design into commercialisation, and to do so with the confidence that our high-quality product meets our goal of providing an effective, much-needed global diagnostic solution in an emergency situation.”

“As a result of our rapid development, we have already received requests from customers in countries across the world to purchase tests.

“Sales and shipments of products will be fulfilled from our Utah headquarters to customers who have the capacity to utilise RUO products to slow the spread of this epidemic.”

Last week, Novacyt’s molecular diagnostics division Primerdesign launched a molecular RUO test for 2019-nCoV.

Meanwhile, the coronavirus outbreak, which originated from China’s Hubei province, has affected a total of 26 countries.

Medical Device Network Excellence Awards - Nominations Closed

Nominations are now closed for the Medical Device Network Excellence Awards. A big thanks to all the organisations that entered – your response has been outstanding, showcasing exceptional innovation, leadership, and impact

Excellence in Action
SC MEDICA’s minimally invasive, radiation free spinal facet fixation system, FFX® is transforming spinal pain management and improving outcomes for surgeons and patients alike. Learn how SC MEDICA’s award-winning technology is redefining standards in facet joint pain treatment.

Discover the Impact